Tanaka, Junji

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Moreau, P., Dimopoulos, M.-A., Mikhael, J., Yong, K., Capra, M., Facon, T., Hajek, R., Špička, I., Baker, R., Kim, K., et al. (2021) · The Lancet

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 392

Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules

Shimoda, H., Tanaka, J., Shan, S.-J., & Maoka, T. (2010) · Journal of Pharmacy and Pharmacology

melanin and skin pigmentationSkin Protection and Aging

Cited by 152

Continuous hepatocyte growth factor supply prevents lipopolysaccharide‐induced liver injury in rats

Kaido, T., Yamaoka, S., Seto, S.-I., Funaki, N., Kasamatsu, T., Tanaka, J., Nakamura, T., & Imamura, M. (1997) · FEBS Letters

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 42